Close Menu

Roger Moody

Roger Moody has joined Clinical Genomics as chief financial officer. He will direct the firm's strategic and tactical financial operations. Moody had been CEO of GlySure, where he remains a director. Prior to that, he was CFO at Nanosphere; executive VP, managing director, and COO at Indegene; and CFO at Medsn before that firm was acquired by Indegene.


Ann Rhoads

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.